0000950170-24-015205.txt : 20240214 0000950170-24-015205.hdr.sgml : 20240214 20240214160518 ACCESSION NUMBER: 0000950170-24-015205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tousignant Jennifer CENTRAL INDEX KEY: 0002010978 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36483 FILM NUMBER: 24637708 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BLDG. 17, SUITE 401 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viridian Therapeutics, Inc.\DE CENTRAL INDEX KEY: 0001590750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 471187261 STATE OF INCORPORATION: DE FISCAL YEAR END: 1215 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BLDG. 17, SUITE 401 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 617.272.4600 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BLDG. 17, SUITE 401 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC. DATE OF NAME CHANGE: 20170213 FORMER COMPANY: FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC. DATE OF NAME CHANGE: 20170213 FORMER COMPANY: FORMER CONFORMED NAME: SIGNAL GENETICS, INC. DATE OF NAME CHANGE: 20140710 4 1 ownership.xml 4 X0508 4 2024-02-12 0001590750 Viridian Therapeutics, Inc.\DE VRDN 0002010978 Tousignant Jennifer C/O VIRIDIAN THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 401 WALTHAM MA 02453 false true false false Chief Legal Officer false Stock Option (Right to Buy) 19.68 2024-02-12 4 A false 290000 0.00 A 2034-02-12 Common Stock 290000 290000 D The option vests as to 25% on February 12, 2025 and then in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service to Issuer through each vesting date. /s/ Jennifer Tousignant 2024-02-14